Other
Ovarian Cyst
10
Pipeline Programs↗
2
Active Trials↗
6
Companies Involved↗
Ovarian cyst is an early-stage landscape with 10 programs across 6 companies. The most active players are Solvay Pharmaceuticals, AbbVie, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.. 4 therapies are approved with 3 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 33
Analysis
Trial Status
9
clinical trials
Unknown status5 · 56%
Recruiting2 · 22%
Completed2 · 22%
Clinical Trials
Trial Activity
9 trials
GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst
Unknown status·—·Phase 4·NCT04993924·15 enrolled
The Efficacy of Progestins in Treatment of Functional Ovarian Cyst
Unknown status·—·Phase 1·NCT03456570·90 enrolled
Are the Combined Oral Contraceptive Pills Needed for Management of the Simple Ovarian Cysts in Reproductive Women?
Unknown status·—·Phase 2/3·NCT03357640·118 enrolled
A Trial of Norethisterone Acetate and Expectant Management in Treatment of Simple Ovarian Cysts
Unknown status·—·Phase 4·NCT05293574·66 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)